Condition: Lung Cancer (Diagnosis) · Sarcoidosis · Chronic Obstructive Pulmonary Disease · Sponsor: Université Catholique de Louvain
This study aims to better understand the role of immune system cells in lung diseases such as lung cancer, sarcoidosis, and chronic obstructive pulmonary disease (COPD). The investigators are studying how these immune cells can sometimes help the body defend itself, but in other cases may contribute to cancer growth or long-term lung inflammation. Although recent treatments like immunotherapy have improved cancer care, only a small proportion of patients currently benefit from these therapies. One goal of this research is to understand why some patients do not respond or develop resistance to treatment. The knowledge gained from this study may help researchers develop more effective and personalized treatments for people with lung diseases in the future.
This description comes directly from the study's public registry record.
Frank Aboubakar Nana, MD; PhD · 0032 2 764 85 19 · frank.aboubakar@saintluc.uclouvain.be
Kim Henquin, Study nurse · 0032 2 764 42 26 · kim.henquin@saintluc.uclouvain.be
Always discuss trial participation with your own doctor first.
| Cliniques universitaires saint Luc | Brussels, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07384897